Advisors Asset Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Advisors Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $57,033 - $66,528	-592 Reduced 12.97%	3,971 $408,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $22,537 - $23,835	-210 Reduced 4.4%	4,563 $498,000
Q3 2022 Nov 08, 2022	BUY	$58.92 - $84.67 $28,104 - $40,387	477 Added 17.24%	3,244 $201,000
Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $64,552 - $94,600	813 Added 41.61%	2,767 $221,000
Q1 2022 May 17, 2022	BUY	$86.42 - $109.81 $34,913 - $44,363	404 Added 26.06%	1,954 $206,000
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $91,463 - $111,276	928 Added 149.2%	1,550 $167,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $27,940 - $33,552	304 Added 95.6%	622 $68,000
Q2 2021 Jul 30, 2021	SELL	$86.24 - $95.92 $66,577 - $74,050	-772 Reduced 70.83%	318 $30,000
Q1 2021 May 07, 2021	SELL	$71.83 - $95.48 $37,279 - $49,554	-519 Reduced 32.26%	1,090 $100,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $58,625 - $73,841	-875 Reduced 35.23%	1,609 $118,000
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $137,191 - $198,546	2,484 New	2,484 $193,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.